New Zealand Clears Kimberly-Clark Kenvue Deal with Feminine Hygiene Divestment
In this article (7)
New Zealand’s Commerce Commission has approved Kimberly-Clark’s acquisition of Kenvue. Clearance requires the business to divest Kenvue’s feminine hygiene operations across New Zealand and Australia.
This divestment covers regional rights to brands including Carefree and Stayfree. The condition aims to prevent excessive market concentration on supermarket shelves.
Conditions for Clearance Across Australasia
Kimberly-Clark is acquiring Kenvue, the consumer health spin-off from Johnson & Johnson, in a global takeover. Under an undertaking given to the regulator, Kimberly-Clark must sell the entire Kenvue feminine care unit in both countries to an approved independent buyer.
Commerce Commission deputy chair Anne Callinan said the remedy protects competition across personal care aisles, where both suppliers held overlapping product lines.
Supermarket Consolidation and Buyer Timelines
Australasian retailers face tightening supplier networks as multinational consumer goods groups consolidate personal care portfolios. Selling Carefree and Stayfree keeps an independent supplier in play against Kimberly-Clark’s Kotex and U by Kotex lines.
Attention now turns to the asset sale. Kimberly-Clark must secure a commission-approved buyer within a confidential, binding timeframe to finalize the broader merger clearance.
Questions & Answers
Q.Which specific brands are Kimberly-Clark required to divest?
Which specific brands are Kimberly-Clark required to divest?
Kimberly-Clark must divest the regional rights to feminine hygiene brands including Carefree and Stayfree. This is part of the condition for the acquisition of Kenvue to proceed in New Zealand and Australia.
Q.What was the Commerce Commission's main reason for imposing the divestment condition?
What was the Commerce Commission's main reason for imposing the divestment condition?
The condition was imposed to prevent excessive market concentration on supermarket shelves and to protect competition across personal care aisles. Both Kimberly-Clark and Kenvue had overlapping product lines in this category.
Q.Who must approve the buyer for the divested feminine hygiene assets?
Who must approve the buyer for the divested feminine hygiene assets?
Kimberly-Clark must sell the entire Kenvue feminine care unit to an approved independent buyer. The Commerce Commission must approve the buyer to finalise the broader merger clearance.
Q.Why is selling Carefree and Stayfree considered important for competition?
Why is selling Carefree and Stayfree considered important for competition?
Selling these brands ensures an independent supplier remains in the market. This helps to maintain competition against Kimberly-Clark's existing Kotex and U by Kotex lines, addressing concerns about tightening supplier networks.
Reader pulse
What is the key impact of this divestment?
21,703 votes so far